The Evolving Provenance of Obviousness-type Double Patenting (Live MBHB Webinar)

Tues., March 19, 2019 | 10:00-11:15 a.m. CT | Live MBHB Webinar via WebEx

Obviousness-type double patenting (“ODP”) is a judicially created doctrine that seeks to prevent patent owners from extending patent protection beyond the statutorily afforded term. This webinar will explore the evolving provenance of obviousness-type double patenting in addressing the following topics:

  • Traditional confines of the doctrine
  • Federal Circuit expansion in Sun Pharma and Gilead
  • Retrenchment in Breckenridge Pharma and Ezra Ventures
  • Future prospects

MBHB partners Kevin Noonan, Ph.D. and Sarah Fendrick, Ph.D.

McDonnell Boehnen Hulbert & Berghoff LLP is committed to educating clients and friends of the firm with respect to significant developments and trends in the areas of intellectual property law.

NOTE: MCLE credit is not available for this archived recording. 

Access an archived audio version of this webinar here